J1120Acetazolamid sodium injectio
Published CMS Medicare Part B payment-limit context for J1120, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$28.127
per 500 MG · Medicare Part B
Up 15.5%from $24.36 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$29.6531$15.6999
2024-Q4: $23.65; 2025-Q1: $21.618; 2025-Q2: $19.061; 2025-Q3: $17.226; 2025-Q4: $19.842; 2026-Q1: $25.594; 2026-Q2: $24.36; 2026-Q3: $28.127
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Acetazolamide Sodium ingredient family (FDA data as of August 20, 2026).
Acetazolamide Sodium
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.